Condition

Active Cutaneous Lupus Erythematosus (1)

Systemic Lupus Erythematosus (1)

Overall Status

Completed (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

Biogen (1)

Collaborator

Intervention

biib059 (1)

placebo (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

active cutaneous lupus erythematosus

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Systemic Lupus Erythematosus, Active Cutaneous Lupus Erythematosus Trial in Worldwide (BIIB059, Placebo)

Completed

Systemic Lupus Erythematosus
Active Cutaneous Lupus Erythematosus

BIIB059
Placebo

Anniston, Alabama
+128 more

Aug 27, 2020